Allergy Therapeutics PLC
27 February 2006
Allergy Therapeutics plc ("the Company")
The Company received notification on 24 February 2006 that Fidelity
International Limited ("FIL") and its direct and indirect subsidiaries,
including Fidelity Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST),
Fidelity Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments
Management (Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and
Fidelity Investments International (FII), investment managers for various non-US
investment companies and institutional clients, are together interested in a
total of 8,120,044 ordinary shares in the Company, representing approximately
12.90 per cent. of the Company's issued share capital.
This shareholding is registered as follows:
Shares held Management Company Nominee/Registered Name
1,366,900 FPM Northern Trust London
579,100 FPM Mellon Bank
568,100 FPM JP Morgan
543,062 FPM Bank of New York Brussels
439,684 FPM State Str Bk and Tr Co Lndn
277,700 FPM Bankers Trust London
150,100 FPM Midland Securities Services
85,300 FPM Clydesdale Bank plc
3,385,298 FISL JP Morgan
397,100 FIL Brown Bros Harrimn Ltd Lux
142,400 FIL Bank of New York Brussels
185,300 FIL JP Morgan
8,120,044 Total holding
This notifiable interest also comprises the notifiable interest of Mr Edward C.
Johnson III, a principal shareholder of Fidelity International Limited, and
interests held on behalf of authorised unit trust schemes in the United Kingdom.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.